Senior insider sale
CAAO and PAO at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$2.17M
73.42K shares
What this filing means
GILLIS JONATHAN plans to sell 73.42K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $2.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/27/2026ACC: 0001950047-26-003775
Officer· CAAO and PAO
Since Feb 2026
73.42K
Shares to sell
$2.17M
Approx. market value
69.83K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted Stock Units
N/A
7/5/2024
48.48KRestricted vesting of Pre IPO shares
N/A
8/19/2019
21.35KTotal acquired69.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/5/2024 | Restricted Stock Units N/A | 48.48K | — |
8/19/2019 | Restricted vesting of Pre IPO shares N/A | 21.35K | — |
| Total | 69.83K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.59K
Market value
$95.5K
4/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
69.83K
Market value
$2.08M
4/27/2026
Total
Units
73.42K
Value
$2.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/15/2026 | 3.59K | $95.5K | — | Completed |
| Planned — Approximate Date | ||||
4/27/2026 | 69.83K | $2.08M | NASDAQ | Planned |
| Total | 73.42K | $2.17M | ||